Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Pediatr Allergy Immunol ; 33(1): e13663, 2022 01.
Artigo em Inglês | MEDLINE | ID: mdl-34480816

RESUMO

BACKGROUND: Food allergy is a potentially life-threatening disease, affecting up to 10% of the pediatric population. OBJECTIVE: The aim of our study was to assess the health-related quality of life (HRQL) of food-allergic patients compared with the general population and patients with other chronic diseases with dietary or allergic burden, in a cross-sectional study. METHODS: We recruited patients aged 8-17 years diagnosed with food allergy and matched healthy controls recruited in schools. We also included patients with asthma, inflammatory bowel disease, celiac disease, diabetes, obesity, and eating disorders. We used the CHQ-CF87 questionnaire for generic HRQL assessment. Food allergy HRQL was also assessed using specific questionnaires: Food Allergy Quality of Life Questionnaire (FAQLQ) and Food Allergy Independent Measure (FAIM). RESULTS: One hundred and thirty-five food-allergic children, 255 children with chronic diseases, and 463 healthy controls were included in the analyses. Food-allergic patients had a better HRQL than healthy controls in the Behavior (BE), Bodily Pain (BP), Family Activities (FA), and Mental Health (MH) domains and a worse HRQL in the General Health Perception (GH) domain (p = .048). Food-allergic patients exhibited a better HRQL than patients affected by other chronic diseases, notably diabetes. Although an epinephrine autoinjector had been prescribed to 87.4% of the food-allergic children, only 54.2% of them carried it at all times. CONCLUSION: Food-allergic patients display overall good HRQL compared with the general population and those with other diseases with daily symptoms and treatments, in line with recent improvements in food allergy management.


Assuntos
Hipersensibilidade Alimentar , Qualidade de Vida , Adolescente , Criança , Estudos Transversais , Humanos , Saúde Mental , Inquéritos e Questionários
2.
Arch Pediatr ; 28(1): 101-103, 2021 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33250331

RESUMO

Beta thalassemias are autosomal recessive hemoglobin disorders related to a defect in the beta-globin chain production. Most of the major forms of beta-thalassemia are transfusion dependent leading to iron overload. Today, three iron chelators are available in France. We report the case of a patient suffering from ß+ major transfusion-dependent thalassemia who presented with severe skin reactions to deferoxamine and deferasirox as well as with agranulocytosis after deferiprone administration. The patient benefited from successful tolerance induction to deferasirox. With the increasing number of children suffering from iron overload, we believe that our protocol can be useful to pediatric hematology teams confronted with multiple iron chelator reactions.


Assuntos
Deferasirox/efeitos adversos , Dessensibilização Imunológica/métodos , Toxidermias/terapia , Quelantes de Ferro/efeitos adversos , Talassemia beta/tratamento farmacológico , Pré-Escolar , Deferasirox/uso terapêutico , Toxidermias/etiologia , Humanos , Tolerância Imunológica , Lactente , Quelantes de Ferro/uso terapêutico , Talassemia beta/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA